Join The Conversation! Talk about the news of the day with public radio fans on WAMU 88.5's The Conversation.
Thursday February 16, 2006
Join the show: 1-800-433-8850 (drshow@wamu.org) or contact us
Week of February 13, 2006
Your Amazon.com purchases support WAMU 88.5
Your purchases from the NPR Store support WAMU 88.5
A scientific advisory panel voted 8 to 7 to recommend that the strongest possible safety warning be added to the labeling for certain drugs used to treat attention-deficit/hyperactivity disorder. A panel talks about what's behind this recommendation and how these drugs are being used and abused.
Dr. Steven Nissen, cardiologist at the Cleveland Clinic and a member of the FDA advisory panel that voted to recommend the strongest possible safety warning on certain drugs used to treat AD/HD
Dr. Jay Salpekar, director of outpatient psychiatry services at Children's National Medical Center
Dr. Lawrence H. Diller, behavioral developmental pediatrician practicing in Walnut Creek, Ca. and a member of the clinical faculty at the University of California--San Francisco. Author of "Running on Ritalin."
Lew Mills, psychotherapist in private practice in San Francisco who is taking medication for AD/HD, as are his two children
A look at how the world's largest retailer is transforming the American economy.
Charles Fishman, senior writer, Fast Company
We're redesigning the web site for The Diane Rehm Show. If you have an idea or feature request share it with us! Or, vote on ideas from other fans of the show!
privacy policy - terms of use - contact - sitemap - directions - rss - podcasts - jobs - community
Copyright WAMU 88.5 American University Radio | 4000 Brandywine Street NW | Washington, DC 20016-8082 | (202)885-1200
